Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse
Abstract:Several prospective studies on dermatological findings in human immunodeficiency virus (HIV) type 1 infected patients have been published, mostly in populations in which the predominant risk factor for HIV infection is homosexuality. We attempted to identify cutaneous diseases associated with HIV-1 infection and to assess disease progression in a cohort of Spanish patients in whom the predominant cause of HIV infection was intravenous drug abuse. We prospectively examined 1161 HIV-1-positive patients for 38 mo… Show more
“…This indicates that appearance of orocutaneous manifestations in a case of HIV infection is sinister and indicates advanced disease. Others have also made similar observations [6][7][8][9][10][11]17].…”
Section: Discussionsupporting
confidence: 62%
“…However, in our study all the 7 cases with oral candidiasis had CD4 counts less than 200, with a mean of 105.28 per cmm, thus fulfilling the AIDS case definition. Thus, the development of oropharyngeal candidiasis shows an advance degree of immunosuppression, as has also been suggested by Munoz-Perez et al [8].…”
Section: Oral Candidiasis and Cd4 Countsupporting
confidence: 53%
“…Only two (18.18%) of our patients were in the group of AIDSdefining criteria with CD4 counts < 200/cmm. Hence seborrhoeic dermatitis should not be considered as an AIDS-defining condition, as has also been reported by others [8,20]. In one series, excessive Pityrosporum organisms were found in only a minority of biopsy specimens from AIDS patients with seborrhoeic dermatitis [21].…”
Section: Seborrhoeic Dermatitis and Cd4 Countmentioning
confidence: 83%
“…Oral candidiasis is the most common opportunistic infection in HIV-infected individuals [8,14]. It is a category B condition, and by itself does not fall in AIDS case definition [18].…”
“…This indicates that appearance of orocutaneous manifestations in a case of HIV infection is sinister and indicates advanced disease. Others have also made similar observations [6][7][8][9][10][11]17].…”
Section: Discussionsupporting
confidence: 62%
“…However, in our study all the 7 cases with oral candidiasis had CD4 counts less than 200, with a mean of 105.28 per cmm, thus fulfilling the AIDS case definition. Thus, the development of oropharyngeal candidiasis shows an advance degree of immunosuppression, as has also been suggested by Munoz-Perez et al [8].…”
Section: Oral Candidiasis and Cd4 Countsupporting
confidence: 53%
“…Only two (18.18%) of our patients were in the group of AIDSdefining criteria with CD4 counts < 200/cmm. Hence seborrhoeic dermatitis should not be considered as an AIDS-defining condition, as has also been reported by others [8,20]. In one series, excessive Pityrosporum organisms were found in only a minority of biopsy specimens from AIDS patients with seborrhoeic dermatitis [21].…”
Section: Seborrhoeic Dermatitis and Cd4 Countmentioning
confidence: 83%
“…Oral candidiasis is the most common opportunistic infection in HIV-infected individuals [8,14]. It is a category B condition, and by itself does not fall in AIDS case definition [18].…”
“…2 HIV-positive subjects with psoriasis present with more extensive, severe, acral forms, and treatment is challenging, when putting into balance potential risks and benefits, as well as adverse reactions. 3 Close monitoring of the patient is mandatory, and collaboration with the infectious disease specialist is essential.…”
Psoriasis is a systemic chronic immune-mediated disorder, rarely reported in HIV-infected patients, in which the disease is more severe and debilitating. Response to treatment is modest, and skin diseases may profoundly affect the patients' quality of life. Anti-psoriasis therapies have immunosuppressive effects and must be carefully recommended in HIV-infected patients. Moreover, the compliance of HIV patients diagnosed with psoriasis is low, and monitoring these patients is challenging. Herein we present a rare case of severe HIV-associated psoriasis with large plaques localized on the trunk, abdomen, limbs and plantar area in a non-compliant patient, with impaired renal and hepatic functions, dyslipidemia, and anemia, for whom the therapeutic approach was disappointing.
Subjects: Fifty-seven consecutive subjects with biopsyproved EF from the pathology database. Subject groups were as follows: naïve to ART, receiving ART without protease inhibitors/nonnucleoside reverse transcriptase inhibitors, and receiving ART containing protease inhibitors/ nonnucleoside reverse transcriptase inhibitors. Main Outcome Measures: Onset of EF, CD4 cell count and nadir at EF onset, and time of ART initiation. Results: Among the 3 groups previously described, mean CD4 cell counts (86.26/µL vs 113.82/µL vs 145.65/µL, respectively [Kruskal-Wallis rank sum test, P=.15]) and nadir (68.43/µL vs 66.18/µL vs 64.17/µL, respectively [Kruskal-Wallis rank sum test, P= .41]) at EF diagnosis were not statistically different. Fifty-two subjects (91%), regardless of treatment group, had a nadir below 200/ µL. Of the subjects undergoing ART, 28 (82%) developed EF within 6 months of initiating ART; their average CD4 cell count increase was 108/µL. Of the 23 subjects receiving protease inhibitor/nonnucleoside reverse transcriptase inhibitor-containing ART regimens, 17 (74%) were diagnosed as having EF within 3 months, with 4 additional subjects diagnosed as having EF within 6 months (a total of 21 [91%] of the 23 subjects). This is not significantly different from the 7 (64%) of 11 subjects diagnosed as having EF at 3 and 6 months of starting ART without protease inhibitors/nonnucleoside reverse transcriptase inhibitors (P=.07) (odds ratio, 0.18; 95% confidence interval, 0.01-1.54). Conclusions: Our study shows an association between low nadir (66.28/µL) and low CD4 cell count (115.54/ µL) and the development of EF, regardless of subjects' ART status. However, most subjects receiving ART were diagnosed as having EF within 3 to 6 months of ART initiation, regardless of the regimen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.